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Abstract
Background: In our previous study, allogeneic-transplanted peripheral nerve segments preserved for one month in
a polyphenol solution at 4°C could regenerate nerves in rodents demonstrated the same extent of nerve
regeneration as isogeneic fresh nerve grafts. The present study investigated whether the same results could be
obtained in a canine model.
Methods: A sciatic nerve was harvested from a male beagle dog, divided into fascicules of < 1.5 mm diameter,
and stored in a polyphenol solution (1 mg/ml) for one month at 4°C. The nerve fascicles were transplanted into 10
female beagle dogs to bridge 3-cm right ulnar nerve gaps. In the left ulnar nerve in each dog, a 3-cm nerve
segment was harvested, turned in the opposite direction, and sutured in situ. Starting one day before
transplantation, the immunosuppressant FK506 was administered subcutaneously at doses of 0.1 mg/kg daily in
four dogs (PA0.1 group), 0.05 mg/kg daily in four dogs (PA0.05 group), or 0.05 mg/kg every other day in two dogs
(PA0.025 group). Twelve weeks after surgery, electrophysiological and morphological studies were performed to
assess the regeneration of the right and left ulnar nerves. The data for the right ulnar nerve were expressed as
percentages relative to the left ulnar nerve. Polymerase chain reaction (PCR) was used to identify the sex-
determining region of the Y-chromosome (Sry) and b-actin to investigate whether cells of donor origin remained
in the allogeneic nerve segments. FK506 concentration was measured in blood samples taken before the animals
were killed.
Results: The total myelinated axon numbers and amplitudes of the muscle action potentials correlated significantly
with the blood FK506 concentration. Few axons were observed in the allogeneic-transplanted nerve segments in
the PA0.025 group. PCR showed clear Sry-specific bands in specimens from the PA0.1 and PA0.05 groups but not
from the PA0.025 group.
Conclusions: Successful nerve regeneration was observed in the polyphenol-treated nerve allografts when
transplanted in association with a therapeutic dose of FK506. The data indicate that polyphenols can protect nerve
tissue from ischemic damage for one month; however, the effects of immune suppression seem insufficient to
permit allogeneic transplantation of peripheral nerves in a canine model.
Background
Autogenous nerve grafting is a widely accepted method
for treating peripheral nerve injuries with nerve deficits.
However, the sources of donor nerves are limited, and
donor site morbidity is inevitable. The shortage of nerve
sources for transplantation is a serious problem in auto-
genous nerve grafting. Nerve allografts performed in
association with the administration of an immunosup-
pressant provide an alternative to autogenous nerve
grafts [1,2]. However, nonspecific immunosuppressive
treatments are often followed by opportunistic infection
of nonpathological viruses or neoplasm formation [3-5].
* Correspondence: kakinoki@kuhp.kyoto-u.ac.jp
2Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto
University, Kyoto, Japan
Full list of author information is available at the end of the article
Nakayama et al. Journal of Brachial Plexus and Peripheral Nerve Injury 2010, 5:17
http://www.jbppni.com/content/5/1/17 JOURNAL OF BRACHIAL PLEXUS AND 
PERIPHERAL NERVE INJURY
© 2010 Nakayama et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.It is controversial whether immunosuppressants should
be administered with nerve allografts when repairing
peripheral nerve injuries with nerve deficits because
such injuries are not usually life threatening.
Green tea polyphenols are intriguing because they
protect tissues from ischemia, have antineoplastic and
anti-inflammatory effects, and suppress immune
responses [6-9]. In our previous studies, peripheral
nerve allografts preserved for one month in a green tea
polyphenol solution were able to regenerate nerves in a
manner similar to that of fresh nerve autografts in a
rodent model, suggesting that peripheral nerve segments
treated with green tea polyphenols might provide an
alternative to autogenous nerve grafts. The observation
that the nerve segments could be preserved for one
month in the green tea polyphenol solution suggested
that treatment with polyphenols could change allogeneic
nerve transplantation from an emergency operation to a
scheduled operation. However, in our semiquantitative
PCR study, only 14% of cells survived in the polyphe-
nol-treated allografts, whereas about 62% of cells sur-
vived in the fresh nerve isografts [10]. These results
suggested that nerve regeneration from the polyphenol-
treated nerve allografts would be inferior to that from
fresh nerve isografts when applied to long nerve gaps or
in highly developed animals such as dogs, primates, and
human beings. We hypothesized that the combination
of immunosuppressants administered with polyphenol
treatment would lead to successful nerve regeneration
with nerve allografts.
In the present study, we performed 3-cm-long allo-
geneic nerve grafts on the right ulnar nerve and 3-cm-
long isogeneic nerve grafts on the left ulnar nerve in a
canine model given one of three doses of an immuno-
suppressant (FK506) [11-13]. We examined the relation-
ship between nerve regeneration in the nerve allografts
and blood FK506 level to investigate whether polyphenol
treatment can reduce the dosage of the immunosuppres-
sant needed to obtain successful nerve regeneration in
the allogeneic nerve transplant.
Methods
Polyphenols
A polyphenol mix extracted from green tea was pur-
chased from PFI, Inc. (Kyoto, Japan). It comprised
mainly (-)-epigallo-catechin-3-O-gallate (28%), (-)-gallo-
catechin-3-O-gallate (11.6%), (-)-epicatechin-3-O-gallate
(4.6%), (-)-epigallocatechin (15.0%), (+)-gallocatechin
(14.8%), (-)-epicatechin (7.0%), and (+)-catechin (9.5%),
and its purity exceeded 90%.
Animals
One male beagle dog (18 kg) and 10 female beagle dogs
(15 kg) were used in this study. The male animal was
purchased from a different breeder from the one supply-
ing the female animals. Each animal was acclimatized
before the surgical procedures, housed in a separate
cage, and given standard dog food and water three
times a day. All experiments were performed in accor-
dance with the guidelines of the Animal Research Com-
mittee, Graduate School of Medicine, Kyoto University,
Japan. The female animals were divided into three
groups and received subcutaneous injections of one of
three doses of FK506: 0.1 mg/kg every day to four ani-
mals (PA0.1 group), 0.05 mg/kg every day to four ani-
mals (PA0.05 group), and 0.05 mg/kg every other day to
two animals (PA0.025 group).
Surgery
Anesthesia
Animals were sedated with 0.2 mg/kg acepromazine
given subcutaneously. After intubation, general anesthe-
sia was induced by inhalation with 5% isoflurane. After
confirming that the animals were nonresponsive to sti-
mulation of the eyelashes, surgery started.
Harvesting nerve allografts and preservation
The male animal was placed in the prone position, and
the sciatic nerve was harvested. The sciatic nerve was
exposed from the sciatic notch to the popliteal fossa in
the interval between the hamstring muscles to obtain a
10-cm-long nerve segment in the midthigh level. The
nerve segment was separated into fascicles under an
operating microscope, and the fascicles were harvested.
The diameter of the fascicles was < 1.5 mm, and the
length was > 5 cm [10]. The fascicles were immersed at
4°C in Dulbecco’s modified Eagle’s medium (DMEM)
containing the polyphenols (1 mg/ml) for one week and
then transferred to DMEM solution alone and immersed
in DMEM for three more weeks.
Transplantation of the preserved nerve segments
Recipient female animals were anesthetized in the
supine position as described above, and a skin incision
was made on the right lower forelimb. The ulnar nerve
was exposed by retracting the ulnar carpal flexor
muscle medially and the digital flexors laterally. A
2.5-cm-long ulnar nerve segment was removed at the
midportion of the lower forelimb. The sciatic nerve fas-
cicles harvested from the male animal and preserved
for one month were taken from the DMEM solution.
Because the diameter of the ulnar nerve was almost 2
mm in the middle of the lower forelimb, two fascicles–
a thick fascicle of 1.2-1.5-mm diameter and a thin fas-
cicle of 0.5-0.8-mm diameter–were transplanted as the
nerve graft. The length of the nerve grafts was adjusted
to 3 cm just before transplantation. Each 3-cm-long
nerve segment comprising the two fascicles was inter-
posed between the proximal and distal nerve stumps of
the ulnar nerve using 10-0 epineural sutures in the
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plantation) (Figure 1).
I nt h el e f tf o r e l i m b ,t h eu l n a rn e r v ew a se x p o s e di n
the same way as in the right forelimb. A 3-cm-long
nerve segment was removed in the middle of the lower
forelimb. The nerve segment was turned in the opposite
direction and sutured in situ (the model for isogeneic
nerve transplantation).
In all animals, FK506 administration was started one
day before the transplantation.
Electrophysiological study
Twelve weeks after nerve transplantation, all recipient
animals were anesthetized as described above. The right
ulnar nerve was exposed and stimulated 3 cm distal to
the elbow joint (S1) and 2 cm proximal to the wrist
joint (S2) with a bipolar silver electrode. A pair of plate
electrodes was fixed over the prominence of the muscles
at the base of the most ulnar digit (hypothenar muscles)
to check for the presence of action potentials in the
muscles. The motor nerve conduction velocity (MNCV)
was calculated for both types of evoked action potentials
stimulated at S1 and S2. The amplitude (peak to peak)
of action potentials evoked in the hypothenar muscles
with the supramaximal electric stimulation was
measured. The same procedure was performed on the
left forelimb.
The values for the action potential amplitude evoked
in the hypothenar muscles and the MNCV for the right
ulnar nerve (the allogeneic-transplanted nerve) were
expressed as percentages of the values for the left ulnar
nerve (the isogeneic-transplanted nerve) and are pre-
sented as %action potential amplitude and %MNCV,
respectively, for each animal.
Morphological study
After the electrophysiological study, a 1-cm-long nerve
segment was harvested from both ulnar nerves 1 cm
distal to the transplanted nerve segments, fixed in 1%
glutaraldehyde and 1.44% paraformaldehyde, postfixed
with 1% osmic acid, and embedded in epoxy resin.
Transverse sections (1 μm thick) were taken from the
midportion of the segment. Transverse sections were
harvested about 1.5 cm distal to the distal neurorrhaphy
of the transplanted nerve segments. The section was
stained with 0.5% (w/v) toluidine blue solution and
examined by light microscopy. Light microscope images
of the specimens were downloaded to a personal com-
puter using Photoshop software (Version 5; Adobe Sys-
tems Inc., San Jose, CA). The total number of
myelinated axons and mean myelinated axon diameter
were calculated on each specimen using Image Pro Plus
software (Media Cybernetics, Silver Spring, MD).
Briefly, the entire neural area (a) of each specimen was
calculated on an image. Six or seven fields were chosen
at random so that the area analyzed would be > 20% of
the entire neural area of each specimen. The number of
myelinated axons, the neural area, and the shortest dia-
meter of each myelinated axon were calculated for each
field. The total number of myelinated axons (b) and
neural areas (c) of six or seven fields were calculated.
The total number of myelinated axons in each specimen
was estimated as b × a/c. The mean myelinated axon
diameter (in μm) is expressed as the average value of
the shortest diameter of all myelinated axons in the six
or seven fields [10,14,15].
The total axon number and mean axon diameter of
the right ulnar nerve (the nerve allograft model) are
expressed as percentages of those of the left ulnar nerve
(the nerve isograft model) and are presented as %total
axon number and %mean axon diameter, respectively,
for each animal.
Measurement of blood FK506 concentration and sacrifice
of animals
After harvesting the nerve specimens for the morpholo-
gical study, a 5-ml blood sample was obtained from
each animal using percutaneous needle puncture of the
heart. A lethal dose of pentobarbital (100 mg/kg/body
Figure 1 Nerve transplantation. A nerve allograft comprising two
fascicles of the donor sciatic nerve. (B) An intraoperative
photograph of allogeneic nerve transplantation. Two fascicles of the
donor sciatic nerve were interposed between the proximal and
distal stumps of the ulnar nerve in the middle of the right lower
forearm.
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mals. Blood FK506 concentration was measured in the
recipient animals by enzyme-linked immunosorbent
assay (ELISA) using an anti-FK506 monoclonal antibody
[16].
Genomic study
Polymerase chain reaction (PCR) was used to investigate
the origin of cells in the nerve allografts in the recipient
animals using primers specific for the sex-determining
region of the canine Y-chromosome (Sry)a n db-actin
genes. After the electrophysiological study, a 1-cm-long
nerve segment was taken from the center of each nerve
allograft in the right ulnar nerve of all animals. Genomic
DNA was extracted from each nerve segment using phe-
nol-chloroform extraction and quantified spectrophoto-
metrically. PCR amplification was performed as
described below. The reaction mixture included 0.001
μg of genomic DNA, 0.5 U Taq DNA polymerase
(AmpliTaq Gold, PerkinElmer Cetus, Shelton, CT), 1
pM of each oligonucleotide primer, 2 μlo fa2 . 5m M
solution of each dNTP, 2.5 μl of 10× PCR buffer, and
1.5 μl of 1.5 mM MgCl2 in a final volume of 25 μl. The
primer sequences used were as follows: canine Sry gene,
5’-CTC GCG ATC AAA GGC GCA AGA T-3’ and 5’-
TTC GGC TTC TGT AAG CAT TTT C-3’; and canine
b-actin gene, 5’-TCC TGT GGC ATC CAC GAA ACT-
3’ and 5’-GAA GCA TTT GCG GTG GAC GAT-3’.
PCR was performed in a thermal cycler (PerkinElmer
Cetus) for 32 cycles of denaturation (94°C, 45 s), anneal-
ing (60°C, 45 s), and extension (72°C, 60 s). The product
was analyzed by electrophoresis on a 2% agarose gel fol-
lowed by ethidium bromide staining [17,18].
Statistical analysis
Correlation coefficients were calculated between the
blood FK506 level and the %action potential amplitudes,
% M N C V s ,% t o t a la x o nn u m b e r s ,a n d% m e a na x o nd i a -
meters using SPSS for Windows (Version 17.0, SPSS
Inc., Chicago, IL). A p-value < 0.05 was considered
significant.
Results
Electrophysiological study
Twelve weeks after transplantation, all animals in the
PA0.1 and the PA0.05 groups displayed evoked action
potentials in the right hypothenar muscles, whereas no
animal in the PA0.025 group displayed evoked action
potentials in the right hypothenar muscles. The mean %
muscle action amplitude was 100% (range 69.8-151.4%)
in the PA0.1 group and 34.7% (range 9.7-60.6%) in the
PA0.05 group. The mean %MNCV was 80.1% in the
PA0.1 group and 61.4% in the PA0.05 group. The blood
FK506 concentration and %muscle action potential
amplitudes correlated significantly (correlation coeffi-
cient = 0.88, p = 0.002). The blood FK506 concentration
and %MNCV did not correlate significantly (correlation
coefficient = 0.70, p = 0.054) (Figure 2).
Morphological study
There were marked differences in the pattern of nerve
regeneration between the groups (Figure 3). Myelinated
axons were seen in all transverse sections taken about
1.5 cm distal to the distal neurorrhaphy of the right
ulnar nerves in the PA0.1 and PA0.05 groups, whereas
few myelinated axons were observed in the nerve allo-
grafts of the PA0.025 group. This finding suggests that
the polyphenol treatment combined with the subcuta-
neous administration of FK506 at the low dose of 0.05
mg/kg every other day did not prevent immune rejec-
tion of the transplanted nerve segments. The mean %
total axon numbers were 86.8% in the PA0.1 group,
35.0% in the PA0.05 group, and 0% in the PA0.025
group. The average %mean axon diameters were 80.2%
in the PA0.1 group, 52.2% in the PA0.05 group, and 0%
in the PA0.025 group. The blood FK506 concentration
correlated significantly with the %total axon number
(correlation coefficient = 0.91, p < 0.001). The FK506
concentration did not correlate significantly with the %
mean axon diameters (correlation coefficient = 0.56, p =
0.153) (Figure 4).
Blood FK506 concentration
The blood FK506 concentration differed markedly
between dogs, even within the same group. The concen-
trations were 11-19 ng/ml (mean 14.6 ng/ml) in the
PA0.1 group, 4-9 ng/ml (mean 6.9 ng/ml) in the PA0.05
group, and 1.0 and 2.5 ng/ml in the two dogs in the
PA0.025 group.
Genomic study
Sufficient genomic DNA to perform semiquantitative
PCR was extracted from all nerve allograft specimens in
each group. The concentrations of the extracted DNA
were 321.2-406.5 μg/ml in the PA0.1 group, 272.8-359.7
μg/ml in the PA0.05 group, and 81.8 μg/ml and 120.6
μg/ml in the PA0.025 group. Less DNA was extracted
from nerve specimens in the PA0.025 group than in the
PA0.1 and PA0.05 groups. PCR products specific to
b-actin were detected in all samples in all groups. Sry-
specific bands were detected in all samples in the PA0.1
and PA0.05 groups, but neither specimen demonstrated
the Sry-specific band in the PA0.025 group (Figure 5).
These results indicate that cells originating from the
donor nerves remained in the nerve allografts in the
PA0.1 and PA0.05 groups but that no cells of donor ori-
gin survived in the nerve allografts in the PA0.025
group.
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Page 4 of 8Figure 2 Electrophysiological study. Blood FK506 concentration (x-axis) and amplitude of action potentials evoked in the hypothenar muscles
(y-axis) of each animal 12 weeks after transplantation. The FK506 concentration correlated significantly with the amplitude of the muscle action
potentials (correlation coefficient = 0.88, p = 0.002). (B) Blood FK506 concentration (x-axis) and motor nerve conduction velocity (y-axis) of each
animal 12 weeks after transplantation. The FK506 concentration did not correlate significantly with the MNCV (correlation coefficient = 0.70, p =
0.054).
Figure 3 Morphological study. Light microscopic examination of transverse sections of the left ulnar nerve 1.5 cm distal to the distal
neurorrhaphy of the nerve isograft (A, a) and allografts (B-D and b-d) 12 weeks after transplantation. (A-D) 100× magnification and a-d; 400×
magnification. (A, a) Nerve isograft in the PL0.1 group; (B, b) nerve allografts in the PL0.1 group; (C, c) nerve allografts in the PL0.05 group; (D, d)
nerve allografts in the PL0.025 group. (D, d) A very few myelinated axons were seen in the PL0.025 group.
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The present study demonstrated that the extent of nerve
regeneration of nerve allografts preserved in polyphenols
for one month in association with the administration of
0.1 mg/kg/day of FK506 was more than 80% of that
achieved with fresh nerve isografts. The %total myelinated
axon number and %muscle action potential amplitude
correlated strongly with the blood FK506 concentration
in the recipient animals. PCR of the Sry region showed
that cells originating in the allogeneic-transplanted nerve
segments survived in the transplanted segments in dogs
given 0.05 mg/kg/day of FK506.
FK506 (tacrolimus) is an immunosuppressant drug
used widely in humans to prevent immune rejection of
organ or tissue transplants [11-13]. The clinical litera-
ture shows that in humans, a dose of 10-20 ng/ml of
FK506 is adequate to prevent rejection and that this
dose is less than that associated with adverse effects fol-
lowing allogeneic organ or tissue transplantation
[11-13]. We used a smaller dose in our study. Oike and
Talpe reported that a blood FK506 concentration of 7-
20 ng/ml led to successful allogeneic liver transplanta-
tion in miniature swine that were genetically semi-iden-
tical [19,20]. We observed nerve regeneration > 80% of
that of the isogeneic nerve transplantation in the PA0.1
group, whose blood FK506 concentrations were > 10
ng/ml. Previous studies showed that nerve regeneration
through fresh nerve allografts in association with a ther-
apeutic dose of FK506 was similar to that of fresh nerve
isografts [21,22]. Dogs transplanted with isogeneic scia-
tic nerve fascicles to the ulnar nerve might demonstrate
almost the same level of nerve regeneration as those
observed in the PA0.1 group.
High doses of FK506 have an anti-ischemic effect, and
lower doses that maintain the blood FK506 concentration
Figure 4 Morphological study with blood FK 506 concentration. Blood FK506 concentration (x-axis) and %-total axon number (y-axis) of
each animal 12 weeks after transplantation. The FK506 concentration correlated significantly with the number of regenerated axons (correlation
coefficient = 0.88, p = 0.002). The %-total axon number of each animal is expressed as the percentage of the total myelinated axon number in
the right ulnar nerve divided by that in the left ulnar nerve. (B) Blood FK506 concentration (x-axis) and %-mean axon diameter (y-axis) of each
animal 12 weeks after transplantation. The FK506 concentration did not correlate significantly with the mean axon diameter (correlation
coefficient = 0.70, p = 0.054). The %-mean axon diameter of each animal is expressed as the percentage of the mean myelinated axon diameter
in the right ulnar nerve (allogeneic nerve transplantation) divided by that in the left ulnar nerve (isogeneic nerve transplantation).
Figure 5 Genomic study.P C Rs p e c i f i ct oc a n i n eSry and b-actin.
(Lanes 1-4) PL0.1 group, (lanes 5-8) PL0.05 group, (lanes 9 and 10)
PL0.025 group. (Upper row) b-actin-specific bands, (lower row) Sry-
specific bands. b-actin-specific bands, but not Sry-specific bands,
were seen in the specimens from the PL0.025 group.
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against ischemia [23]. Polyphenols protected the nerve
segments from ischemic damage when the transplanted
nerve segments were preserved for one month. We won-
dered whether the polyphenol treatment of the trans-
planted nerve segments contributed to the suppression of
immunological reactions following the allogeneic trans-
plantation. Although the precise mechanisms of immuno-
suppression by polyphenols are not understood fully,
several papers have suggested that epigallocatechin gallate
(EGCG), the main component of polyphenols, has immu-
nosuppressive actions [24-27]. Our previous study using a
rat model demonstrated successful nerve regeneration in
polyphenol-treated nerve segments transplanted between
major histocompatibility-mismatched rats, although only
14% of the cells of donor origin remained in the nerve
segments 12 weeks after the transplantation [10]. The
degree of nerve regeneration using nerve allografts trea-
ted with polyphenols correlated significantly with the
blood FK506 concentration in dogs in our present study.
The immunosuppressive effects of polyphenols might not
be strong enough to prevent immune system-induced tis-
sue rejection following allogeneic transplantation in dogs,
which have a more highly developed immune system
compared with rodents.
In the present study, the donor sciatic nerve segment
was divided into fascicles of < 1.5 mm, which were used
for transplantation. Our previous studies demonstrated
that immersion of a large-diameter nerve segment in the
polyphenol solution for one month at 4°C was asso-
ciated with the destruction of Schwann cells deeper
than 0.7-0.8 mm below the perineural surface of the
nerve segment. We suspected that the permeability of
polyphenols into the peripheral nerve segments was <
0.7-0.8 mm from the perineural surface of nerves. The
study revealed that the sciatic nerve segment should be
divided into fascicles of < 1.4-1.6 mm before the poly-
phenol treatment [15]. It is known that FK506 has neu-
roprotective and neuroregenerative effects [28,29]. In
the present study, we calculated the electrophysiological
and morphological data of the nerve allografts as per-
centages relative to the nerve isografts in the contralat-
eral forelimb to minimize the facilitative effect of FK506
on nerve regeneration.
Axons extended successfully through the nerve allo-
grafts that had been immersed in the polyphenol solution
for one month when transplanted in association with a
t h e r a p e u t i cd o s eo fF K 5 0 6i nac a n i n em o d e l .A l t h o u g h
polyphenols have a strong anti-ischemic action, the ability
to suppress immune rejection may not be strong enough
to suppress the immunological rejection following allo-
geneic transplantation in animals such as the dog, which
has a highly developed immune system.
Conclusions
In contrast to our previous findings in a rodent model
using 2-cm-long nerve allografts, immersion of nerve
segments in the polyphenol solution alone did not pre-
vent immune rejection following the allogeneic trans-
plantation of the segments in dogs. Our data suggest
that polyphenol immersion in association with a thera-
peutic dose of FK506 might lead to successful nerve
regeneration in higher animals. The polyphenols pro-
tected the nerve allografts from ischemic damage but
did not completely suppress immune rejection episodes
induced by the allotransplantation against the grafts.
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